Canada Markets open in 6 hrs 5 mins

Worldwide Transfection Reagents and Equipment Industry to 2026 - Technological Advancements in Transfection are Driving Growth -

·3 min read

DUBLIN, October 22, 2021--(BUSINESS WIRE)--The "Transfection Reagents and Equipment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to's offering.

The major factors that are driving the market growth include technological advancements in transfection, an increase in R&D expenditure and research activities by pharmaceutical and biotech companies, and a rise in demand for synthetic genes.

Companies Mentioned

  • Bio-Rad Laboratories, Inc.

  • Lonza Group

  • MaxCyte Inc.

  • Merck KGaA

  • Mirus Bio LLC

  • Polyplus-transfection SA

  • Promega Corporation

  • Qiagen N.V.

  • Thermo Fisher Scientific Inc.

Key Market Trends

Pharmaceutical & Biotechnology Companies are Expected to Hold a Significant Share in the End User Segment

The rapid progress of cell and gene therapies through clinical development is fueling the demand for late-stage clinical and commercial manufacturing capabilities. Transient transfection for vector production offers noteworthy flexibility for cell and gene therapy development. Pharmaceutical and biotechnology companies with the ability to achieve high-yielding clinical and commercial manufacturing of high-quality viral vectors using transient transfection are now offering their clients this flexibility combined with scalability and speed to market.

Moreover, the global pharmaceutical industry investment in research and development has increased over the years, Hence, with the increasing R&D expenditure, the market in the pharmaceutical industry is expected to attain a good growth over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the global market studied. Research in the region, especially in the United States, is widely believed to be essential to the economic growth of North America, and the innovations derived from basic and applied research provide enormous benefits to society. For this reason, the federal government devotes a significant amount of funding towards biopharmaceutical products research. Hence, the US is expected to dominate the global market over the forecast period as well.

Key Topics Covered:





4.1 Market Overview

4.2 Market Drivers

4.2.1 Technological Advancements in Transfection

4.2.2 Increase in R&D Expenditure and Research Activities by Pharmaceutical and Biotech Companies

4.2.3 Rise in Demand for Synthetic Genes

4.3 Market Restraints

4.3.1 High Cost of Transfection Reagents

4.3.2 Selective Effectiveness and Certain Limitations of Transfection Reagents

4.4 Porter's Five Force Analysis


5.1 By Product

5.1.1 Reagents

5.1.2 Equipment

5.2 By Method

5.2.1 Biochemical Methods

5.2.2 Physical Methods

5.2.3 Viral Methods

5.3 By End User

5.3.1 Pharmaceutical & Biotechnology Companies

5.3.2 Academics & Research Institutes

5.4 Geography


6.1 Company Profiles


For more information about this report visit

View source version on

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting